|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/315 | (2006.01) |
| C12N 7/00 | (2006.01) | ||
| A61K 48/00 | (2006.01) |
| (11) | Number of the document | 3645553 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18749636.9 |
| Date of filing the European patent application | 2018-06-27 | |
| (97) | Date of publication of the European application | 2020-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-15 |
| (46) | Date of publication of the claims translation | 2023-04-25 |
| (86) | Number | PCT/US2018/039878 |
| Date | 2018-06-27 |
| (87) | Number | WO 2019/006046 |
| Date | 2019-01-03 |
| (30) | Number | Date | Country code |
| 201762525708 P | 2017-06-27 | US |
| (72) |
SABIN, Leah , US
SCHOENHERR, Christopher , US
ECONOMIDES, Aris N. , US
KYRATSOUS, Christos , US
MURPHY, Andrew J. , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Modifikuoto tropizmo rekombinantinės viruso dalelės ir jų panaudojimas genetinės medžiagos tiksliniam įvedimui į žmogaus ląsteles |
| TROPISM-MODIFIED RECOMBINANT VIRAL PARTICLES AND USES THEREOF FOR THE TARGETED INTRODUCTION OF GENETIC MATERIAL INTO HUMAN CELLS |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 8 | 185.00 EUR |
| 2026-06-27 |